Isolated antiplasmin deficiency presenting as a spontaneous bleeding disorder in a 63-year-old man

Spontaneous bleeding in adults is a major problem, and in a significant number of these patients no cause is found. A 63-year-old Caucasian man presented to our hematology clinic with a large hematoma of his left thigh. Initial investigations did not show any conclusive abnormalities of primary or secondary hemostasis. Subsequent tests demonstrated a type 1 deficiency of antiplasmin. Treatment with low doses of ϵ-aminocaproic acid resulted in resolution of the hematoma and control of bleeding. We sought to determine the cause of the patient's isolated antiplasmin deficiency but no explanation was found. Three heterozygous polymorphisms were identified in his antiplasmin gene, ruling out major gene deletions. Each of these three polymorphisms has been previously reported in healthy blood donors. Finally, since response to antifibrinolytics can be dramatic, deficiencies of antiplasmin must be considered in patients presenting at any age with a spontaneous bleeding disorder.

[1]  P. McKee,et al.  Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. , 2006, Blood.

[2]  R. Favier,et al.  Congenital α2‐plasmin inhibitor deficiencies: a review , 2001 .

[3]  B. Lind,et al.  A novel missense mutation in the human plasmin inhibitor (alpha2‐antiplasmin) gene associated with a bleeding tendency , 1999, British journal of haematology.

[4]  K. Fukutake,et al.  Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age. , 1996, Thrombosis Research.

[5]  K. Roux,et al.  High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. , 1996, BioTechniques.

[6]  R. Sokol,et al.  Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage. , 1993, The American journal of pediatric hematology/oncology.

[7]  A. Johnsen,et al.  Different N-terminal forms of α2-plasmin inhibitor in human plasma , 1993 .

[8]  U. Francke,et al.  Assignment of the human α2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids , 1992 .

[9]  O. Miura,et al.  Expression and characterization of pro alpha 2-plasmin inhibitor. , 1989, Journal of biochemistry.

[10]  O. Miura,et al.  Organization of the human alpha 2-plasmin inhibitor gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Nelles,et al.  Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin). , 1987, The Journal of biological chemistry.

[12]  S. Rapaport,et al.  Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management. , 1985, Blood.

[13]  N. Aoki Genetic Abnormalities of the Fibrinolytic System , 1984, Seminars in thrombosis and hemostasis.

[14]  Aoki Nobuo,et al.  The α2-plasmin inhibitor levels in liver diseases , 1978 .

[15]  D. Collen Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. , 1976, European journal of biochemistry.

[16]  R. Favier,et al.  Congenital alpha(2)-plasmin inhibitor deficiencies: a review. , 2001, British journal of haematology.

[17]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[18]  A. Johnsen,et al.  Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma. , 1993, The Biochemical journal.

[19]  U. Francke,et al.  Assignment of the human alpha 2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids. , 1992, Genomics.

[20]  N. Aoki,et al.  The alpha2-plasmin inhibitor levels in liver diseases. , 1978, Clinica chimica acta; international journal of clinical chemistry.